192 related articles for article (PubMed ID: 7673727)
1. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
Watson GA; Lopez DM
J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
Fu YX; Watson GA; Kasahara M; Lopez DM
J Immunol; 1991 Jan; 146(2):783-9. PubMed ID: 1824777
[TBL] [Abstract][Full Text] [Related]
3. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
[TBL] [Abstract][Full Text] [Related]
4. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
Fu Y; Paul RD; Wang Y; Lopez DM
J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
[TBL] [Abstract][Full Text] [Related]
5. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
6. [A change in antigen presentation ability of spleen macrophage from Balb/c mouse during late pregnancy].
Tan Z; Li S; Cao Z; Zhao Z; Ma Q; Huang Z; Li L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):674-7. PubMed ID: 14619578
[TBL] [Abstract][Full Text] [Related]
7. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
8. Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.
Carrio R; Lopez DM
Int J Mol Med; 2009 Jan; 23(1):89-98. PubMed ID: 19082511
[TBL] [Abstract][Full Text] [Related]
9. CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine.
Cheng X; Lopez DM
J Immunol; 1998 Mar; 160(6):2735-41. PubMed ID: 9510174
[TBL] [Abstract][Full Text] [Related]
10. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
Handel-Fernandez ME; Cheng X; Herbert LM; Lopez DM
J Immunol; 1997 Jan; 158(1):280-6. PubMed ID: 8977200
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
Xie Y; Fernandez ME; Streilein JW; Lopez DM
Anticancer Res; 1996; 16(1):9-16. PubMed ID: 8615675
[TBL] [Abstract][Full Text] [Related]
13. The role of lipocortin I in macrophage-mediated immunosuppression in tumor-bearing mice.
Sakata T; Iwagami S; Tsuruta Y; Teraoka H; Hojo K; Suzuki S; Sato K; Suzuki R
J Immunol; 1990 Jul; 145(1):387-96. PubMed ID: 2141618
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
Prina E; Jouanne C; de Souza Lão S; Szabo A; Guillet JG; Antoine JC
J Immunol; 1993 Aug; 151(4):2050-61. PubMed ID: 8102156
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.
Gabrilovich DI; Ciernik IF; Carbone DP
Cell Immunol; 1996 May; 170(1):101-10. PubMed ID: 8665590
[TBL] [Abstract][Full Text] [Related]
16. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
17. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
18. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
19. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
20. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
Shanahan TC; Ceglowski WS; Havas HF
Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
